# EGFR Bioactivity Prediction - Project Summary

## ğŸ¯ Executive Summary

Built an ensemble machine learning model to predict EGFR inhibitor bioactivity with **94.54% ROC-AUC**, validated on FDA-approved drugs with 100% accuracy, and deployed as an interactive Streamlit web application.

## ğŸ“Š Key Achievements

- âœ… Collected and processed 20,033 compounds from ChEMBL
- âœ… Engineered 12 molecular descriptors using RDKit
- âœ… Trained 4 models: RF, XGBoost, Neural Network, Ensemble
- âœ… Achieved 94.54% ROC-AUC (publication-quality)
- âœ… 100% validation accuracy on 8 known drugs
- âœ… Deployed production-ready Streamlit application

## ğŸ† Model Performance

**Best Model:** Weighted Ensemble (70% RF + 15% XGB + 15% NN)
- ROC-AUC: 0.9454
- Accuracy: 92.94%
- Precision: 95.56%
- Recall: 96.03%

## ğŸ’¼ Skills Demonstrated

### Technical Skills
- Python programming (pandas, numpy, scikit-learn)
- Cheminformatics (RDKit molecular descriptors)
- Machine learning (ensemble methods, neural networks)
- Model evaluation (ROC-AUC, cross-validation)
- Web deployment (Streamlit)

### Domain Knowledge
- Drug discovery pipeline understanding
- EGFR cancer biology
- Structure-activity relationships (SAR)
- Lipinski's Rule of Five (drug-likeness)

### Software Engineering
- Clean code architecture
- Model serialization and deployment
- Version control (Git)
- Documentation

## ğŸ“ˆ Business Impact

**Value Proposition:**
- Reduces experimental screening costs by computationally filtering compounds
- Accelerates drug discovery timeline from years to months
- Enables virtual screening of millions of compounds
- Industry relevance: AI drug discovery market projected $14.2B by 2032

## ğŸ¤ Interview Talking Points

1. **"Walk me through your project"**
   - Collected 25K compounds â†’ Calculated descriptors â†’ Trained ensemble â†’ Validated on FDA drugs â†’ Deployed web app

2. **"What challenges did you face?"**
   - Class imbalance (7:1 ratio) â†’ Solved with SMOTE
   - RDKit descriptor calculation â†’ Fixed FractionCsp3 import issue
   - Deployment â†’ Used Streamlit for internal tool standard

3. **"What would you improve?"**
   - Add Morgan fingerprints for richer features
   - Multi-task learning for multiple cancer targets
   - SHAP values for explainable AI
   - Deploy to cloud (AWS/Streamlit Cloud)

4. **"How does this relate to bioinformatics?"**
   - Similar to genomics pipelines (data â†’ features â†’ ML â†’ insights)
   - ChEMBL API like NCBI/EBI databases
   - Transferable to protein-ligand binding prediction

## ğŸ“ Resume Bullets
```
- Developed ensemble ML pipeline (Random Forest, XGBoost, Neural Network) to predict 
  EGFR inhibitor bioactivity using 20,033 compounds from ChEMBL database, achieving 
  94.54% ROC-AUC with 100% validation accuracy on FDA-approved drugs

- Engineered 12 molecular descriptors using RDKit cheminformatics library and applied 
  SMOTE oversampling to handle 7:1 class imbalance, improving model generalization

- Deployed interactive Streamlit web application with single and batch prediction 
  capabilities, demonstrating production-ready ML deployment skills
```

## ğŸ“ Learning Outcomes

- âœ… End-to-end ML project experience
- âœ… Cheminformatics expertise (RDKit)
- âœ… Ensemble learning techniques
- âœ… Model validation best practices
- âœ… Web application deployment
- âœ… Pharmaceutical domain knowledge

## ğŸ“… Timeline

**6-Day Sprint:**
- Day 1: Data collection (ChEMBL API)
- Day 2: Preprocessing & descriptors
- Day 3: Model training & optimization
- Day 4: Validation with known drugs
- Day 5: Streamlit deployment
- Day 6: Documentation & finalization

---

**Created by Vedant Kulkarni | Northeastern University | Bioinformatics MS**
